Indacaterol/glycopyrronium reduces the risk of clinically important deterioration in patients with moderate copd: results from the crystal study
Source: Respirology - Category: Respiratory Medicine Tags: APSR Poster Abstracts Source Type: research
More News: Chronic Obstructive Pulmonary | Study